A research study identified new genes that may be associated with a higher risk for triple negative breast cancer. Out of 100 people with breast cancer about 15 will have triple-negative breast cancer (TNBC). It’s one of the most challenging types of breast cancer to treat due to several things: TNBC tends to be more […]
Study: New Genes Linked With Triple Negative Breast Cancer Read More »
The US Food and Drug Administration (FDA) has approved the first treatment of its kind for a certain type of breast cancer caused by an inherited genetic mutation. Piqray (alpelisib) is a targeted therapy called a PI3K inhibitor. It’s specifically for advanced breast cancer patients – postmenopausal women and men – whose tumors have the PIK3CA mutation and are hormone receptor (HR)
FDA Approves First PI3K Inhibitor for Breast Cancer Read More »
A mammogram is an important step in taking care of yourself and your breasts. A mammogram is a low-dose x-ray that allows specialists to look for changes in breast tissue that aren’t normal. The American Cancer Society recommends that women at average risk of breast cancer – most women – should begin having yearly mammograms at age 45, and can change
What to Know About Getting a Mammogram Read More »
Managing weight is a challenge for many people in the US. In fact, according to the Centers for Disease Control and Prevention, more than 70% of American adults are overweight. This puts them at higher risk for serious conditions, including diabetes, heart disease, and some types of cancer. According to research from the American Cancer Society, excess
The Link Between Weight and Cancer Risk Read More »
The US Food and Drug Administration today approved the first immunotherapy treatment for breast cancer. It approved a combination of Tecentriq (atezolizumab) and Abraxane (nab-paclitaxel) for people with advanced triple negative breast cancer. This is significant because there are few treatments available for this type of breast cancer, and it tends to grow and spread faster than
FDA Approves Immunotherapy for Breast Cancer Read More »
